Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03608228 · ClinicalTrials.gov registry record
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 27
- Enrollment target
NCT03608228: Completed study, sponsored by University of California, Los Angeles.
NCT03608228 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03608228 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The brain networks controlling movement are complex, involving multiple areas of the brain. Some neurological diseases, like Parkinson's disease, cause abnormalities in the brain networks. Deep brain stimulation is a treatment that is used to treat these types of neurological diseases. Through this research, the investigators will take advantage of the unique opportunity provided by awake deep brain stimulation surgery to learn more about how the brain functions in a diseased state and how deep brain stimulation changes these networks. This study aims to enroll up to 75 subjects over a period of 2.5 years. Those who participate in the study will spend up to 40 minutes during their deep brain stimulation surgery during which researchers will record signals from deep structures within the brain as well as the surface of the brain using electrodes that are temporarily placed for research purposes. During the study, researchers will record signals while subjects perform three different tasks, in some cases while the brain is stimulated. Study participation is limited to the intraoperative environment with no additional study visits required.
Primary Outcome
Patients will be asked to perform hand movements in response to either a go signals, a conflict signal, or a stopping signal.
Interventions
- OTHER Measuring electrical signals from the brain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-12-06 |
| Est. Completion | 2020-11-10 |
What the finished NCT03608228 record still lists
NCT03608228 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Measuring electrical signals from the brain is the first listed.
NCT03608228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03608228 about?
NCT03608228 is a clinical study titled "Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks". The brain networks controlling movement are complex, involving multiple areas of the brain. Some neurological diseases, like Parkinson's disease, cause abnormalities in the brain networks. Deep brain stimulation is a treatment that is used to treat these types of neurological diseases. Through this ...
What is the current status of trial NCT03608228?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2016-12-06. Estimated completion is 2020-11-10.
What interventions are being tested in trial NCT03608228?
The interventions under investigation include: Measuring electrical signals from the brain (OTHER).
Who is sponsoring clinical trial NCT03608228?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI